Grifola frondosa, commonly known as maitake, is a large, fan-shaped polypore mushroom with centuries of use in Japanese and Chinese traditional medicine. The name translates loosely as “dancing mushroom,” and within the functional mushroom field it has earned significant scientific attention for two primary areas: blood sugar metabolism and immune modulation. This article reviews the current research evidence across both domains.
What Is Maitake?
Grifola frondosa grows at the base of oak, elm, and other hardwood trees, primarily across East Asia, Europe, and North America. It produces large, overlapping fronds that can reach considerable size in mature specimens. Unlike many functional mushroom species consumed primarily as extracts, maitake is also a culinary mushroom with a robust, earthy flavor used in cooking across Japan. Medicinally, the mushroom has been investigated primarily for its beta-1,3/1,6-glucan content, with a particular extract known as D-fraction receiving focused clinical and preclinical attention.
Blood Sugar Research: Polysaccharide Fractions and Insulin Signaling
Among the more mechanistically detailed findings in the maitake literature is research examining how specific polysaccharide fractions from G. frondosa may influence insulin sensitivity at the cellular level. A study published in Food and Function isolated two polysaccharide-enriched fractions, designated F2 and F3, from maitake and tested their effects in a diabetic rat model. Both fractions significantly reduced fasting serum glucose levels, fasting serum insulin levels, and the HOMA-IR index (a measure of insulin resistance) compared to diabetic controls. The researchers examined the underlying mechanism and found that F2 and F3 increased the activity and messenger RNA expression of the insulin receptor (IR) and influenced downstream signaling proteins in the PI3K/Akt pathway, which mediates cellular glucose uptake. F2 also inhibited expression of protein tyrosine phosphatase-1B (PTP1B), an enzyme associated with insulin resistance when overexpressed.[1]
These findings suggest that maitake polysaccharides may influence blood glucose regulation not through a single mechanism but through modulation of insulin receptor signaling at multiple points in the pathway. It is worth noting that this research was conducted in animal models, and extrapolation to human outcomes requires further investigation in well-controlled clinical trials.
PPARdelta Activation and Glucose Tolerance
A complementary line of investigation has explored a different mechanism by which maitake may support glucose metabolism. A 2018 study published in Bioscience, Biotechnology, and Biochemistry found that lipid-soluble extracts from G. frondosa demonstrated peroxisome proliferator-activated receptor delta (PPARdelta) agonist activity in cell culture models. In high-fat diet-induced obese mice, administration of the extract lowered total blood cholesterol, upregulated PPARdelta-target gene expression in skeletal muscle, and improved glucose intolerance. Cell culture experiments with muscle cells also showed that the extract restored glucose uptake that had been inhibited by saturated fatty acids. Notably, some of this glucose-uptake restoration persisted even when a PPARdelta antagonist was added, indicating a PPARdelta-independent insulin signaling component as well.[2]
Together, these two lines of preclinical research suggest that G. frondosa may act through at least two mechanistically distinct pathways relevant to glucose regulation: direct modulation of insulin receptor signaling and activation of nuclear receptor pathways involved in metabolic gene expression. Whether these mechanisms translate to clinically meaningful blood sugar improvements in humans is an area warranting further study.
Immune Research: D-Fraction and Dendritic Cell Activation
The immune research on maitake has concentrated substantially on a soluble beta-glucan fraction called D-fraction, which was identified and characterized largely through work at Kobe Pharmaceutical University. D-fraction interacts with Dectin-1, a pattern recognition receptor expressed on dendritic cells, macrophages, and other innate immune cells. Binding at Dectin-1 activates intracellular signaling cascades that influence cytokine production and immune cell maturation.
A study published in the Journal of Leukocyte Biology examined maitake D-fraction in combination with a Toll-like receptor 9 (TLR9) agonist in a murine tumor model. The combination synergistically increased the expression of dendritic cell maturation markers and interleukin-12 production compared to either agent alone, while not increasing interleukin-10, which is associated with immune suppression. This selectively pro-inflammatory cytokine profile facilitated a T helper 1-type immune response, which is associated with cytotoxic T cell activity. The combination led to measurable tumor regression in treated animals, with increased dendritic cell infiltration at tumor sites and elevated interferon-gamma-producing CD4+ and CD8+ T cells.[3]
While this research is preclinical and situated specifically in an oncology context, it provides mechanistic detail about how maitake D-fraction may interact with the innate and adaptive immune systems. The Dectin-1 activation mechanism it relies on is shared with other beta-glucan-rich mushrooms, though the structural characteristics of each mushroom’s glucan fraction influence exactly how and to what degree activation occurs.
What D-Fraction Does and Does Not Show in Humans
Maitake D-fraction has been evaluated in limited human studies, primarily in the context of cancer patients seeking complementary approaches. A pilot study involving breast cancer patients found some evidence of immunological effects, including changes in immune cell activity markers, though the study was small and not designed to assess clinical outcomes. Reviews of the broader D-fraction literature have characterized it as having “limited proof of clinical efficacy” in humans while noting that the preclinical immune activation data are biologically plausible and that controlled research continues.[4] Larger randomized clinical trials in healthy populations, rather than cancer patients, have not yet been published.
Nutritional Composition
Beyond its bioactive extracts, maitake is nutritionally substantive as a whole food. It provides dietary fiber, B vitamins (including niacin and riboflavin), copper, potassium, and a meaningful amount of ergosterol, which can convert to vitamin D2 upon UV exposure. Among commonly consumed edible mushrooms, maitake is noted for relatively high ergosterol concentrations. Its beta-glucan content is considered among the higher-end of culinary mushroom species, though this varies with cultivation method and processing.
Maitake Within a Broader Functional Mushroom Context
Maitake’s dual research focus on metabolic health and immune function distinguishes it from some other widely studied functional mushrooms. Species like lion’s mane are primarily researched for neurotrophin activity and cognitive support, while turkey tail research is centered on its PSK/PSP polysaccharides in oncology contexts. Maitake occupies a somewhat different niche, with its strongest emerging evidence pointing to glucose metabolism pathways and innate immune activation via Dectin-1. For readers interested in how multiple functional mushrooms may work together across different health systems, our overview of which functional mushrooms work better together provides a useful comparative framework.
Safety and Practical Considerations
Maitake has a long history of culinary use without significant safety concerns. It is generally regarded as well tolerated in both food and supplement forms. Individuals managing blood sugar with insulin or oral hypoglycemic agents should be aware that maitake may have additive effects on glucose regulation and should discuss supplementation with their healthcare provider before starting. Similarly, those taking immunosuppressant medications should consult a physician, as immunomodulatory mushrooms may in theory interact with immune-suppressing drug regimens. Standardized maitake extracts, particularly D-fraction products, typically disclose their beta-glucan or polysaccharide content on the label, which is a useful quality indicator when selecting a supplement.
Summary
The current body of research on Grifola frondosa suggests biologically plausible effects on both blood sugar metabolism and immune function, supported by detailed mechanistic work in preclinical models. Polysaccharide fractions have demonstrated effects on insulin receptor signaling and glucose uptake pathways in animal studies, while lipid-soluble extracts show PPARdelta-mediated improvements in glucose tolerance. The D-fraction preparation has been shown to activate dendritic cells via Dectin-1 and support T helper 1-type immune responses in murine models. Human clinical data remains limited, and the translation of these findings to practical supplementation recommendations awaits larger controlled trials in human populations.
References
- 1. Xiao C, et al. Hypoglycemic effects of Grifola frondosa (Maitake) polysaccharides F2 and F3 through improvement of insulin resistance in diabetic rats. Food Funct. 2015;6(11):3567-75. PMID: 26311233
- 2. Aoki H, et al. Grifola frondosa (Maitake) extract activates PPARdelta and improves glucose intolerance in high-fat diet-induced obese mice. Biosci Biotechnol Biochem. 2018;82(9):1550-1559. PMID: 29873587
- 3. Masuda Y, et al. Soluble beta-glucan from Grifola frondosa induces tumor regression in synergy with TLR9 agonist via dendritic cell-mediated immunity. J Leukoc Biol. 2015;98(6):1015-25. PMID: 26297795
- 4. Kidd PM. The use of mushroom glucans and proteoglycans in cancer treatment. Altern Med Rev. 2000;5(1):4-27. PMID: 10696116
Disclaimer: This article is for informational purposes only and does not constitute medical advice. Functional mushrooms are not intended to diagnose, treat, cure, or prevent any disease. Consult a qualified healthcare professional before making changes to your diet or supplement routine, particularly if you are managing a health condition or taking prescription medications.
